Differential Diagnosis of Hematuria and Required Laboratory Tests
The differential diagnosis of hematuria is broad, ranging from benign causes to serious urologic and renal diseases, requiring a systematic evaluation with specific laboratory tests to determine the source and etiology of bleeding.
Initial Assessment of Hematuria
Classification of Hematuria
- Microscopic hematuria: Defined as ≥3 red blood cells per high-power field on microscopic evaluation of 2 of 3 properly collected urine specimens 1
- Macroscopic (gross) hematuria: Visible blood in urine, carries >10% risk of malignancy 2
Key Distinction: Glomerular vs. Non-Glomerular Source
Determining the source of bleeding is the first critical step:
Glomerular Source Indicators:
- Dysmorphic RBCs (>80% indicates glomerular source) 1
- Red blood cell casts (pathognomonic for glomerular bleeding) 1
- Significant proteinuria (>500-1000 mg/24 hours) 1
- Tea-colored urine 1
Non-Glomerular Source Indicators:
- Normal-shaped RBCs (>80% indicates lower tract bleeding) 1
- Absence of proteinuria and casts 1
- Bright red or pink urine 1
Differential Diagnosis
Glomerular Causes
Systemic diseases with renal involvement:
- Lupus erythematosus
- Vasculitis
- Infections (hepatitis, endocarditis)
- Henoch-Schönlein purpura 1
Primary renal diseases:
Non-Glomerular Causes
Urologic conditions:
Other causes:
Required Laboratory Tests
Basic Initial Tests for All Patients
Comprehensive urinalysis:
- RBC count per high-power field
- RBC morphology (dysmorphic vs. eumorphic) using phase contrast microscopy if available
- Presence of casts, crystals, WBCs
- Protein measurement (dipstick and quantification if positive) 1
Serum creatinine to assess renal function 1
Complete blood count with platelets to evaluate for anemia or coagulopathy 1
Additional Tests Based on Initial Findings
For Suspected Glomerular Disease:
- 24-hour urine protein or spot protein-to-creatinine ratio 1
- Blood urea nitrogen (BUN) 1
- Serum complement levels (C3, C4)
- Antinuclear antibody (ANA), anti-double-stranded DNA
- Hepatitis B and C serology
- ANCA testing if vasculitis suspected
- Audiogram and slit lamp examination if Alport syndrome suspected 1
For Suspected Non-Glomerular Disease:
- Urine calcium-to-creatinine ratio to assess for hypercalciuria 1, 5
- Urine cytology (especially in patients with risk factors for transitional cell carcinoma) 1
- Coagulation studies if bleeding disorder suspected
Imaging Studies Based on Clinical Presentation
For Persistent Unexplained Hematuria:
- Renal and bladder ultrasound as initial imaging 1, 5
- CT urography for patients at high risk for urothelial carcinoma 3
- Cystoscopy for patients with risk factors for bladder cancer 1
Special Considerations
When to Consider Renal Biopsy:
- Persistent glomerular hematuria with proteinuria
- Declining renal function
- Systemic disease with renal involvement 1, 6
When to Refer to Specialists:
- Nephrology: For glomerular disease, persistent unexplained hematuria >2 weeks, or need for renal biopsy 4
- Urology: For gross hematuria, suspected malignancy, or urolithiasis 1, 2
Common Pitfalls to Avoid
- Failure to distinguish glomerular from non-glomerular hematuria - This distinction is crucial for directing further evaluation
- Overlooking benign causes - Always rule out exercise, menstruation, or medication-related hematuria before extensive workup 1
- Inadequate follow-up - Patients with isolated hematuria should be monitored for development of hypertension, proteinuria, or renal insufficiency 1
- Missing malignancy - Gross hematuria carries significant risk of malignancy and requires prompt urologic evaluation 2
By following this systematic approach to the differential diagnosis and laboratory evaluation of hematuria, clinicians can efficiently identify the underlying cause and implement appropriate management strategies.